PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Funding for ATL1103 Phase II Trial and Pipel, page-18

  1. 3,080 Posts.
    lightbulb Created with Sketch. 574
    re: Ann: Funding for ATL1103 Phase II Trial a... Would be very nice to see gains here on ANP like PRR saw, then look at it proportionally to number of products and value or gains in the product and we could easily be sitting on a multi multi bagger.

    Go ANP, its only a matter of time for us IMO.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.